Reprogram Biosciences, a preclinical oncology biotechnology company developing mRNA-based therapeutics to treat solid tumors, today announced the close of its seed financing. The close brings total ...

Scientists from Trinity College Dublin have discovered that electrically stimulating macrophages—one of the immune systems key players—can reprogram them in such a way as to reduce inflammation and ...

A recent commentary article published in the New England Journal of Medicine highlights how targeted dietary manipulations could reprogram tumor biology. The possibility that diet could improve cancer ...